LYRA logo

Lyra Therapeutics (LYRA) Net Income

Annual Net Income

-$62.68 M
-$7.40 M-13.39%

31 December 2023

LYRA Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$11.87 M
+$36.26 M+75.33%

30 September 2024

LYRA Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$97.61 M
+$3.78 M+3.73%

30 September 2024

LYRA TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LYRA Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.4%+24.1%-58.0%
3 y3 years-183.3%-7.4%-164.4%
5 y5 years-939.6%-185.2%-716.6%

LYRA Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-183.3%at low-7.4%+75.3%-164.4%+3.7%
5 y5 years-939.6%at low-185.2%+75.3%-716.6%+3.7%
alltimeall time-939.6%at low-230.8%+75.3%-2619.8%+3.7%

Lyra Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$11.87 M(-75.3%)
-$97.61 M(-3.7%)
June 2024
-
-$48.13 M(+114.4%)
-$101.39 M(+47.2%)
Mar 2024
-
-$22.45 M(+48.1%)
-$68.88 M(+9.9%)
Dec 2023
-$62.68 M(+13.4%)
-$15.16 M(-3.2%)
-$62.68 M(+1.5%)
Sept 2023
-
-$15.65 M(+0.2%)
-$61.76 M(+1.5%)
June 2023
-
-$15.62 M(-3.9%)
-$60.87 M(+2.1%)
Mar 2023
-
-$16.25 M(+14.2%)
-$59.62 M(+7.9%)
Dec 2022
-$55.28 M(+27.0%)
-$14.23 M(-3.6%)
-$55.28 M(+1.1%)
Sept 2022
-
-$14.77 M(+2.8%)
-$54.66 M(+7.3%)
June 2022
-
-$14.37 M(+20.6%)
-$50.95 M(+7.0%)
Mar 2022
-
-$11.91 M(-12.5%)
-$47.62 M(+9.4%)
Dec 2021
-$43.51 M
-$13.62 M(+23.2%)
-$43.51 M(+17.9%)
DateAnnualQuarterlyTTM
Sept 2021
-
-$11.05 M(+0.1%)
-$36.92 M(+14.7%)
June 2021
-
-$11.04 M(+41.5%)
-$32.20 M(+25.3%)
Mar 2021
-
-$7.80 M(+11.1%)
-$25.70 M(+16.1%)
Dec 2020
-$22.13 M(+35.7%)
-$7.02 M(+10.8%)
-$22.13 M(+13.7%)
Sept 2020
-
-$6.33 M(+39.5%)
-$19.46 M(+12.6%)
June 2020
-
-$4.54 M(+7.3%)
-$17.29 M(+2.0%)
Mar 2020
-
-$4.23 M(-2.8%)
-$16.95 M(+3.9%)
Dec 2019
-$16.31 M(+170.5%)
-$4.35 M(+4.6%)
-$16.31 M(+36.4%)
Sept 2019
-
-$4.16 M(-0.9%)
-$11.95 M(+53.4%)
June 2019
-
-$4.20 M(+17.1%)
-$7.79 M(+117.1%)
Mar 2019
-
-$3.59 M
-$3.59 M
Dec 2018
-$6.03 M
-
-

FAQ

  • What is Lyra Therapeutics annual net profit?
  • What is the all time high annual net income for Lyra Therapeutics?
  • What is Lyra Therapeutics annual net income year-on-year change?
  • What is Lyra Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Lyra Therapeutics?
  • What is Lyra Therapeutics quarterly net income year-on-year change?
  • What is Lyra Therapeutics TTM net profit?
  • What is the all time high TTM net income for Lyra Therapeutics?
  • What is Lyra Therapeutics TTM net income year-on-year change?

What is Lyra Therapeutics annual net profit?

The current annual net income of LYRA is -$62.68 M

What is the all time high annual net income for Lyra Therapeutics?

Lyra Therapeutics all-time high annual net profit is -$6.03 M

What is Lyra Therapeutics annual net income year-on-year change?

Over the past year, LYRA annual net profit has changed by -$7.40 M (-13.39%)

What is Lyra Therapeutics quarterly net profit?

The current quarterly net income of LYRA is -$11.87 M

What is the all time high quarterly net income for Lyra Therapeutics?

Lyra Therapeutics all-time high quarterly net profit is -$3.59 M

What is Lyra Therapeutics quarterly net income year-on-year change?

Over the past year, LYRA quarterly net profit has changed by +$3.78 M (+24.14%)

What is Lyra Therapeutics TTM net profit?

The current TTM net income of LYRA is -$97.61 M

What is the all time high TTM net income for Lyra Therapeutics?

Lyra Therapeutics all-time high TTM net profit is -$3.59 M

What is Lyra Therapeutics TTM net income year-on-year change?

Over the past year, LYRA TTM net profit has changed by -$35.85 M (-58.05%)